Benta Pharma Industries (BPI), a local manufacturer of pharmaceuticals, has achieved promising results of an innovation it's working on with Vanderbilt and Harvard universities.
The innovation enables the implantation of a human pancreas inside a human body without the need for immunosuppressive therapy, which makes the body less likely to reject the transplanted organ.
"Implanting subcutaneous human pancreas technology has been available for a long time, but Benta's innovation i...
Article details
No comments:
Post a Comment